1. |
MAXIMILIAN S. The grafting of presevered amniotic membrance to burned and ulcerated surfaces, a substituting skin grafts[J]. JAMA, 1913, 60(13): 973-974.
|
2. |
NIKNEJAD H, PEIROV H, JORJANI M, et al. Properties of the amniotic membrane for potential use in tissue engineering[J]. Eur Cell Mater, 2008, 15: 88-89.
|
3. |
SCHULZE U, HAMPEL U, SEL S, et al. Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing[J]. Histochem Cell Biol, 2012, 138(2): 243-250.
|
4. |
KANG J W, KOO H C, HWANG S Y, et al. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells[J]. J Vet Sci, 2012, 13(1): 23-31.
|
5. |
ASTERN J M, COLLIER A C, KENDAL-WRIGHT C E. Pre-B cell colony enhancing factor (PBEF/NAMP T/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion[J]. Placenta. 2013, 34(1): 42-49.
|
6. |
FRANZ M G, PAYNE W G, XING L, et al. The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models[J]. Eplasty, 2008, 8:e 21.
|
7. |
LOCKINGTON D, COONEY J, LEWIS A, et al. Substance P concentrateon in human amniotic membrane[J]. Arch Ophthalmol, 2012, 130(4): 522-523.
|
8. |
LIU T, ZHAI H, XU Y, et al. Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn[J]. Mol Vis, 2012, 18: 2137-2146.
|
9. |
LI W, HE H, KAWAKITA T, et al. Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro[J]. Exp Eye Res, 2006, 82(2): 282-292.
|
10. |
高健, 刘玲玲, 刘文, 等. 生物羊膜冷冻干燥工艺优化研究[J]. 生物医学工程学杂志, 2012, 29(4): 705-709.
|
11. |
MOSTAQUE A K, RAHMAN K B. Comparisons of the effects of biological membrane (amnion) and silver sulfadiazine in the management of burn wounds in children[J]. J Burn Care Res, 2011, 32(2): 200-209.
|
12. |
ADLY O A, MOGHAZY A M, ABBAS A H, et al. Mohamed assessment of amniotic and polyurethane membrane dressings in the treatment of burns[J]. Burns, 2010, 36(5): 703-710.
|
13. |
BUJANG-SAFAWI E, HALIM A S, KHOO T L, et al. Dried irradiated human amniotic membrane as a biological dressing for facial burns-A 7-year case series[J]. Burns, 2010, 36(6): 876-882.
|
14. |
BRANSKI L K , HERNDON D N, CELIS M M, et al. Amnion in the treatment of pediatric partial-thickness facial burns[J]. Burns, 2008, 34(3): 393-399.
|
15. |
YANG M, LIANG Y , SHENG L , et al. A preliminary study of differentially expressed genes in expanded skin and normal skin: implications for adult skin regeneration[J]. Arch Dermatol Res, 2011, 303(2): 125-133.
|
16. |
CHOI J A, CHOI J S, JOO C K. Effects of amniotic membrane suspension in the rat alkali burn model[J]. Mol Vis, 2011, 17: 404-412.
|
17. |
宋学英, 杨慧春, 齐绍文, 等. 早期羊膜移植治疗眼表烧伤[J]. 实用医药, 2012, 29(1): 26-27.
|
18. |
AMER MI, ABD-EL-MAEBOUD KH, ABDELFATAH I, et al. Human amnion as a temporary biologic barrier after hysteroscopic lysis of severe intrauterine adhesions: pilot study[J]. J Minim Invasive Gynecol, 2010, 17(5): 605-611.
|
19. |
郝鹏, 项舟, 罗静聪, 等. 脱细胞羊膜预防生物衍生肌腱修复鸡屈趾肌腱Ⅱ区缺损修复后的粘连[J]. 中国组织工程研究与临床康复, 2011, 15(3-4): 6355-6359.
|
20. |
单伟, 王长辉, 秦书俭, 等. 人脐带间充质干细胞修复大鼠坐骨神经损伤的实验研究[J]. 中国医科大学学报, 2011, 8(40): 696-702.
|
21. |
GREGORY D G. Treatment of acute Stevens-Johnson syndrome and toxic epidermal necrolysis using amniotic membrane: a review of 10 consecutive cases[J]. Ophthalmology , 2011, 118(5): 908-914.
|
22. |
LOEFFELBEIN D J, BAUMANN C, STOECKELHUBER M, et al. Amniotic membrane as part of a skin substitute for full-thickness wounds: an experimental evaluation in a porcine model[J]. J Biomed Mater Res B Appl Biomater, 2012, 100(5): 1245-1256.
|
23. |
黄建艳, 钟杏霞, 赵能育, 等. 生物型人工皮肤及复合bFGF对兔创面愈合的影响[J]. 中国美容医学, 2010, 10(19): 1493-1496.
|
24. |
LEE P H, TSAI S H, KUO L, et al. A prototype tissue engineered blood vessel using amniotic membrane as scaffold[J]. Acta Biomater, 2012, 8(9): 3342-3348.
|
25. |
REDONDO P, ANA GIMÉNEZ DE AZCARATE , MARQUÉS L, et al. Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo[J]. Dermatol Res Pract, 2011, 2011: 532139.
|
26. |
RESCH M D, RESCH B E, CSIZMAZIA E, et al. Drug reservoir function of human amniotic membrane[J]. J Ocul Pharmacol Ther, 2011, 27(4): 23-326.
|
27. |
ROUBELAKIS M G, TROHATOU O, ANAGNOU N P. Amniotic fluid and amniotic membrane stem cells: marker discovery[J]. Stem Cells Int, 2012, 2012: 107836.
|
28. |
TAUZIN H, HUMBERT P, VIENNET C, et al. Human amniotic membrane in the management of chronic venous leg ulcers[J]. Ann Dermatol Venereol, 2011, 138(8-9): 572-579.
|
29. |
SANT'ANNA L B, CARGNONI A, RESSEL L, et al. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model[J]. Cell Transplant, 2011, 20(3): 441-453.
|
30. |
XUE S, CHEN C, DONG W, et al. Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1ΔE9-deleted genes[J]. Sci China Life Sci, 2012, 55(2): 132-140.
|
31. |
BITSIKA V, VLAHOU A, ROUBELAKIS M G. Fetal mesenchymal stem cells in cancer therapy[J]. Curr Stem Cell Res Ther, 2013, 8(2):133-143.
|